+ Watch OSIR
on My Watchlist
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
Hopefully this speculative pharma red-thumb doesn't hurt me like some others have these past few months. (http://caps.fool.com/Blogs/biopharma-run-up-is-ruining-my/763269) I tend to agree with those who are realistic about the company's recent nod on Prochymal and ask "Yeah, so what?" This is tough for me because I am an absolute believer in the gargantuan impact stem cells will one day have on society. However, there are still too many obstacles and questions that remained to be answered. Maybe in a few years OSIR and ATHX will be on a less risky road.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions